The molecular mechanisms of intestinal inflammation and fibrosis in Crohn's disease

Y Hayashi, H Nakase - Frontiers in physiology, 2022 - frontiersin.org
Crohn's disease (CD) is an inflammatory bowel disease (IBD) with repeated remissions and
relapses. As the disease progresses, fibrosis and narrowing of the intestine occur, leading to …

How to place the duality of specific MMP-9 inhibition for treatment of inflammatory bowel diseases into clinical opportunities?

G Opdenakker, S Vermeire, A Abu El-Asrar - Frontiers in Immunology, 2022 - frontiersin.org
Crohn's disease (CD) and ulcerative colitis (UC) are inflammatory bowel diseases (IBD) with
the involvement of immune cells and molecules, including cytokines, chemokines and …

Mucosal expression of PI3, ANXA1, and VDR discriminates Crohn's disease from ulcerative colitis

JP James, BS Nielsen, IJ Christensen, E Langholz… - Scientific Reports, 2023 - nature.com
Differential diagnosis of inflammatory bowel disease (IBD) to Crohn's disease (CD) or
ulcerative colitis (UC) is crucial for treatment decision making. With the aim of generating a …

Pioglitazone attenuates the effects of peripheral inflammation in a human in vitro blood–brain barrier model

GHO da Rocha, RA Loiola, M de Paula-Silva… - International Journal of …, 2022 - mdpi.com
Biological mediators secreted during peripheral chronic inflammation reach the bloodstream
and may damage the blood–brain barrier (BBB), triggering central nervous system (CNS) …

Prophylactic Catechin-Rich Green Tea Extract Treatment Ameliorates Pathogenic Enterotoxic Escherichia coli-Induced Colitis

JW Kim, CY Kim, JH Kim, JS Jeong, JO Lim, JW Ko… - Pathogens, 2021 - mdpi.com
In this study, we explored the potential beneficial effects of green tea extract (GTE) in a
pathogenic Escherichia coli (F18: LT: STa: Stx2e)-induced colitis model. The GTE was …

Intestinal fibrosis in aganglionic segment of Hirschsprung's disease revealed by single‐cell RNA sequencing

S He, J Wang, Y Huang, F Kong, R Yang… - Clinical and …, 2023 - Wiley Online Library
Background Hirschsprung's disease (HSCR) is a relatively common congenital disability.
Accumulating extracellular matrix (ECM) prompts intestinal fibrosis remodelling in the …

PPARs in Clinical Experimental Medicine after 35 Years of Worldwide Scientific Investigations and Medical Experiments

A Skoczyńska, M Ołdakowska, A Dobosz, R Adamiec… - Biomolecules, 2024 - mdpi.com
This year marks the 35th anniversary of Professor Walter Wahli's discovery of the PPARs
(Peroxisome Proliferator-Activated Receptors) family of nuclear hormone receptors. To mark …

Pioglitazone has a null association with inflammatory bowel disease in patients with type 2 diabetes mellitus

CH Tseng - Pharmaceuticals, 2022 - mdpi.com
Pioglitazone shows potential benefits in inflammatory bowel disease (IBD) in preclinical
studies, but its effect in humans has not been researched. We used a nationwide database …

Pioglitazone as a potential modulator in autoimmune diseases: a review on its effects in systemic lupus erythematosus, psoriasis, inflammatory bowel disease, and …

ME Nasrabadi, A Al-Harrasi… - Expert Review of …, 2024 - Taylor & Francis
Introduction Current medications for autoimmune disorders often induce broad-ranging side
effects, prompting a growing interest in therapies with more specific immune system …

[HTML][HTML] The Versatile Role of Peroxisome Proliferator-Activated Receptors in Immune-Mediated Intestinal Diseases

E Posta, I Fekete, I Varkonyi, E Zold, Z Barta - Cells, 2024 - mdpi.com
Peroxisome proliferator-activated receptors (PPARs) are nuclear receptors that sense
lipophilic molecules and act as transcription factors to regulate target genes. PPARs have …